Delayed preconditioning in cardiac myocytes with respect to development of a proinflammatory phenotype: Role of SOD and NOS

Cardiovascular Research

Volumn 59, Issue 4, 2003, Pages 901-911

  Rui, Tao ^a   Cepinskas, Gediminas ^a   Feng, Qingping ^a   Kvietys, Peter R ^a  

^a LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Hypoxia anoxia; Infection inflammation; Leukocytes; Myocytes; Preconditioning

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANOXIA; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; INFLAMMATION; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION;

ANIMALS; CELLS, CULTURED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; NEUTROPHIL INFILTRATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPEROXIDE DISMUTASE;

EID: 1642387035     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00502-9     Document Type: Article

References (41)

1. Entman M.L., Michael L., Rossen R.D., et al. Inflammation in the course of early myocardial ischemia. FASEB J. 5:1991;2529-2537.
2. Granger D.N., Kubes P. The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J. Leukocyte Biol. 55:1994;662-675.
3. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res. 43:1999;860-878.
4. Carden D., Granger D.N. Pathophysiology of ischemia-reperfusion injury. J Pathol. 190:2001;255-266.
5. Smith E.F., Egan J.W., Bugelski P.J., et al. Temporal relation between neutrophil accumulation and myocardial reperfusion injury. Am. J. Physiol. 255:1988;H1060-H1068.
6. Baxter G.F. The neutrophil as a mediator of myocardial ischemia-reperfusion injury: time to move on. Basic Res Cardiol. 97:2002;268-275.
7. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res. 53:2002;31-47.
8. Hartman J.C., Anderson D.C., Wiltse A.L., et al. Protection of ischemic/reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. Cardiovasc Res. 30:1995;47-54.
9. Lefer D.J., Shandelya S.M., Serrano C.V.J., et al. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury. Circulation. 88:1993;1779-1787.
10. Ma X.L., Lefer D.J., Lefer A.M., et al. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation. 86:1992;937-946.
11. Simpson P.J., Todd R.F., Fantone J.C., et al. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J. Clin. Invest. 81:1988;624-629.
12. Weyrich A.S., Ma X.Y., Lefer D.J., et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:1993;2620-2629.
13. Palazzo A., Jones S., Anderson D.C., et al. Coronary endothelial P-selectin in pathogenesis of myocardial ischemia-reperfusion injury. Am. J. Physiol. (Heart Circ Physiol). 275:1998;H1865-H1872.
14. Palazzo A., Jones S.P., Girod W.G., et al. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice. Am. J. Physiol. (Heart Circ Physiol). 275:1998;H2300-H2307.
15. Cepinskas G., Lush C.W., Kvietys P.R. Anoxia/reoxygenation-induced tolerance with respect to polymorphonuclear leukocyte adhesion to cultured endothelial cells: a nuclear factor-κB phenomenon. Circ Res. 84:1999;103-112.
16. Rui T., Cepinskas G., Feng Q., et al. Cardiac myocytes exposed to anoxia-reoxygenation promote neutrophil transendothelial migration. Am J Physiol Heart Circ Physiol. 281:2001;H440-H447.
17. Ichikawa H., Flores S., Kvietys P.R., et al. Molecular mechanisms of anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Circ Res. 81:1997;922-931.
18. Korthuis R.J., Gute D.C., Cepinskas G., et al. Cellular mechanisms of acute versus delayed preconditioning. Pathophysiology. 5:1998;35-48.
19. Yellon D.M., Baxter G.F., Garcia-Dorado D., et al. Ischaemic preconditioning: present position and future directions. Cardiovasc Res. 37:1998;21-33.
20. Dekker L.R. Toward the heart of ischemic preconditioning. Cardiovasc Res. 37:1998;14-20.
21. Xuan Y.T., Tang X.L., Qiu Y., et al. Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol. 279:2000;H2360-H2371.
22. Osborne D.L., Aw T.Y., Cepinskas G., et al. Development of ischemia/reperfusion tolerance in the rat small intestine. An epithelium-independent event. J. Clin. Invest. 94:1994;1910-1918.
23. Dana A., Jonassen A.K., Yamashita N., et al. Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation. 101:2000;2841-2848.
24. Yamashita N., Nishida M., Hoshida S., et al. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 h after preconditioning. J. Clin. Invest. 94:1994;2193-2199.
25. Vanden Hoek T.L., Shao Z., Li C., et al. Reperfusion injury in cardiac myocytes after simulated ischemia. Am. J. Physiol. 270:1996;H1334-H1341.
26. Zhou X., Zhai X., Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation. 93:1996;1177-1184.
27. Takano H., Manchikalapudi S., Tang X.L., et al. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation. 98:1998;441-449.
28. Guo Y., Jones W.K., Xuan Y.T., et al. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA. 96:1999;11507-11512.
29. Marber M.S. Ischemic preconditioning in isolated cells. Circ Res. 86:2000;926-931.
30. Kvietys P.R., Granger D.N. Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am. J. Physiol. 273:1997;G1189-G1199.
31. Rui T., Cepinskas G., Kvietys P.R. Delayed preconditioning in cardiac myocytes with respect to induction of an oxidant stress: role of NFκB and Mn-SOD. FASEB J. 17:2003;A1075.
32. Kvietys P.R., Cepinskas G., Granger D.N. Neutrophil-endothelial cell interactions during ischemia/reperfusion. Kamada T., Shiga R.S.M. Tissue reperfusion and organ function: ischemia/reperfusion injury. 1996;179-191 Elsevier, Amsterdam.
33. Cepinskas G., Noseworthy R., Kvietys P.R. Transendothelial neutrophil migration. Role of neutrophil-derived proteases and relationship to transendothelial protein movement. Circ Res. 81:1997;618-626.
34. Feng Q., Lu X., Jones D.L., et al. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 104:2001;700-704.
35. Kinugawa K.I., Kohmoto O., Yao A., et al. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am. J. Physiol. 272:1997;H35-H47.
36. Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function. Circ Res. 79:1996;363-380.
37. Grisham M.B., Jourd'heuil D., Wink D.A. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol. 276:1999;G315-G321.
38. Bolli R., Manchikalapudi S., Tang X.L., et al. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning. Circ Res. 81:1997;1094-1107.
39. Semenza G.L. Cellular and molecular dissection of reperfusion injury: ROS within and without. Circ Res. 86:2000;117-118.
40. Wang D., Yang X.P., Liu Y.H., et al. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am J Hypertens. 12:1999;174-182.
41. Herskowitz A., Choi S., Ansari A.A., et al. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 146:1995;419-428.